3 months ago
SYRE
AnalystsDebanjana ChatterjeeDebanjana Chatterjee's Stock Forecasts
AnalystsDebanjana Chatterjee
Sectors:
Industries:
Analyst Ranking
Top 22%
#1187 out of 5337 analysts
Average Return
+30.53%
Win Rate
68%13 out of 19
Risk vs Reward
Poor
Good
Debanjana Chatterjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Spyre Therapeutics IncSYRE | +241.49% | $28.66 | $97.87 | 2025-12-01 - 2026-07-29 | Strong Buy |
Sionna Therapeutics IncSION | +107.26% | $21.62 | $44.81 | 2025-09-08 - 2026-07-29 | Strong Buy |
Contineum Therapeutics IncCTNM | +94.12% | $7.14 | $13.86 | 2025-03-13 - 2026-03-12 | Strong Buy |
Trevi Therapeutics IncTRVI | +69.07% | $10.70 | $18.09 | 2026-03-19 - 2026-07-29 | Strong Buy |
Theravance Biopharma IncTBPH | +57.45% | $10.60 | $16.69 | 2025-06-17 - 2026-06-16 | Strong Buy |
Debanjana Chatterjee Analyst Color
Get additional color on Debanjana Chatterjee's coverage of popular stocks
Debanjana Chatterjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alterity Therapeutics LtdATHE | 1 | Strong Buy | $16.00 | +260.36% | Initiates Coverage On | a month ago |
Sionna Therapeutics IncSION | 2 | Strong Buy | $63.00 | +40.59% | Maintains | 3 months ago |
Spyre Therapeutics IncSYRE | 2 | Strong Buy | $95.00 | -2.93% | Maintains | 3 months ago |
Mindwalk Holdings CorpHYFT | 1 | Strong Buy | $5.00 | +284.62% | Initiates Coverage On | 3 months ago |
Abcellera Biologics IncABCL | 1 | Strong Buy | $11.00 | +104.08% | Initiates Coverage On | 4 months ago |
Trevi Therapeutics IncTRVI | 1 | Strong Buy | $24.00 | +32.67% | Maintains | 4 months ago |
Intellia Therapeutics IncNTLA | 2 | Strong Buy | $29.00 | +168.52% | Upgrades | 5 months ago |
Armata Pharmaceuticals IncARMP | 1 | Strong Buy | $15.00 | +228.23% | Initiates Coverage On | 7 months ago |
Theravance Biopharma IncTBPH | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | a year ago |
Sagimet Biosciences IncSGMT | 2 | Strong Buy | $27.00 | N/A | Maintains | a year ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $39.00 | N/A | Initiates Coverage On | a year ago |
Kalvista Pharmaceuticals IncKALV | 2 | Strong Buy | $30.00 | N/A | Maintains | a year ago |
Contineum Therapeutics IncCTNM | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | a year ago |
Pharvaris NvPHVS | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.